In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GeneCentric Diagnostics Inc.

www.genecentric.com

Latest From GeneCentric Diagnostics Inc.

Hatteras Venture Partners: The 2013 A-List Investor Spotlight

The North Carolina firm convinced investors to pledge $88 million and layered $50 million in federal small-business loans on top. It has quickly put the funds to work.

Medical Device BioPharmaceutical

The A-List: The Trend-Shaping Series A Financings Of 2013

It’s the 10th anniversary of START-UP’s A-List, an analysis of the year’s Series A life science funding, and a highlight of the year’s most interesting new companies. Deal flow was up this year, as was the average disclosed amount of financing.

BioPharmaceutical Medical Device

Financings Of The Fortnight Not Seeing A Trickle-Down Investment Effect From Last Year’s IPOs

The 2013 life sciences IPO boom does not necessarily augur more of the same for those biotechs now lining up to go public. Plus financing news from Juno Therapeutics, GlycoMimetics, Ultragenyx and Alkermes.

Business Strategies

2013: The Year In Diagnostics

Concerns over patents, the anticipated regulatory oversight over complex tests, and reimbursement and evidence development characterized the continued upheaval in the diagnostics industry over the past year. However, genomics tools and technologies continue to be refined and introduced commercially, and companies with a sharp marketplace focus are showing they can still rise to the top.

Medical Device Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GeneCentric Diagnostics Inc.
  • Senior Management
  • Myla Lai-Goldman, MD, CEO
    Michael V Milburn, PhD, CSO
    Walter M Capone, PhD, CBO
  • Contact Info
  • GeneCentric Diagnostics Inc.
    Phone: (919) 973-6544
    79 TW Alexander Dr., 4401 Research Co.
    Sute 105
    Research Triangle Park, NC 27709
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register